Picture of Hyperion DeFi logo

HYPD — Hyperion DeFi News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Formosa Pharmaceuticals And Aimmax Therapeutics Receive FDA Approval For Clobetasol Propionate Ophthalmic Suspension 0.05%

March 4 (Reuters) - Formosa Pharmaceuticals Inc:
    * FORMOSA PHARMACEUTICALS AND AIMMAX THERAPEUTICS RECEIVE
FDA
APPROVAL FOR CLOBETASOL PROPIONATE OPHTHALMIC SUSPENSION 0.05%,
FOR THE TREATMENT OF POST-OPERATIVE INFLAMMATION AND PAIN
FOLLOWING OCULAR SURGERY


 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Hyperion DeFi

See all news